To keep up to date with news from this category use our
Smith & Nephew announces plan to acquire the assets of Nucryst Pharmaceuticals Corp
Hull, UK -11 November 2009 The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE: SNN), announces the signing of a definitive agreement to acquire substantially all of the assets of Nucryst...
Antares Pharma, Inc. (ANTR) Enters into License and Asset Purchase Agreements with Ferring; Majority of Antares Employees Will Become Employees of Ferring
EWING, N.J.--November 11, 2009--Antares Pharma, Inc. (NYSE Amex: AIS) today announced the simultaneous signing of a license and an asset purchase agreement with Ferring International Center S.A. Under the terms of the...
NUVO RESEARCH PROVIDES WF10 LICENSING AND DEVELOPMENT UPDATE
Mississauga, Ontario, Canada - November 11, 2009 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin...
NOVAVAX to Present at the Influenza Congress USA 2009
ROCKVILLE, MD (November 11, 2009) - Novavax, Inc. (NASDAQ: NVAX) a clinical-stage vaccine company, announced today that John Trizzino, Senior Vice President, International and Government Alliances, will be presenting at...
Conclusion of the Agreement on Apaziquone for Non-muscle invasive bladder cancer
November 11, 2009 -- Nippon Kayaku Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Koichiro Shimada) concluded the agreement on apaziquone (generic name) for non-muscle invasive bladder cancer (superficial...
The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma
Milan (Italy), 11 November 2009 - MolMed S.p.A. (Milan:MLM) announces that the European Commission has granted Orphan Drug designation for MolMed's investigational new antitumour therapeutic drug NGR-hTNF in the...
Dow AgroSciences, Chromatin Announce Research, License Agreements
Indianapolis and Chicago - November 11, 2009--Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, and Chromatin Inc. announced today that the companies have entered into two agreements: the...
Life Technologies Signs Definitive Agreement to Acquire BioTrove
CARLSBAD, Calif.--Nov. 10, 2009-- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an...
Life Technologies Signs Definitive Agreement to Acquire BioTrove
CARLSBAD, Calif.--Nov. 10, 2009-- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an...
Duke University & Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership
New Delhi, India, November 10, 2009, 4:00 pm Delhi time/5:30 am ET Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and...
SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders
MENLO PARK, Calif.--November 10, 2009--SRI International, an independent nonprofit research and development organization, announced today that its Center for Neuroscience has entered into a research collaboration with...
ELANTAS strengthens its activities in technologies of the future
Wesel / Munich, November 10, 2009--ELANTAS Electrical Insulation, a leading manufacturer of insulating materials for the electrical and electronics industry, further expands its position in the market segment...
Almac to Speak at Upcoming CDISC Interchange with Technology Partners
November 10, 2009--Almac Clinical Technologies, a leading provider of IVR/IWR technology, announced today that it will be speaking at the upcoming CDISC North American Interchange on a panel with alliance partners...
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
(PRINCETON, New Jersey, and BOTHELL, Washington, November 10, 2009) - Bristol-Myers Squibb Company (NYSE:BMY) and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and...
NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim
PRINCETON, NEW JERSEY - November 10, 2009 - NUCRYST Pharmaceuticals Corp. announced today the execution of a definitive agreement (the "S&N Agreement") with subsidiaries of Smith & Nephew plc. (LSE: SN; NYSE: SNN) for...
Diamyd Technology Advances with US $ 1.84 Million Grant
November 10, 2009--Diamyd Inc, Pittsburgh, PA, USA, a wholly-owned subsidiary of Diamyd Medical, Stockholm Sweden, announces today that the United States Department of Veterans Affairs (VA) has awarded a $1.84 million...
IRONWOOD AND ASTELLAS ANNOUNCE JAPAN LICENSING AGREEMENT FOR LINACLOTIDE
CAMBRIDGE, Mass. and TOKYO, Japan, November 10, 2009-- Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and...
Compumedics' German DWL
Melbourne, Australia, Tuesday, 10 November, 2009--Leading Australia-based medical-devices company, Compumedics Limited (ASX: CMP) is pleased to announce that its Germany based DWL
Cerimon Pharmaceuticals Acquires European Rights to Topical Diclofenac Patch Cerimon Also Completes Enrollment of Phase 3 Diclofenac Patch Studies in Acute Pain Company Also Receives Notice of Allowance for Key US Patent Application
SOUTH SAN FRANCISCO, Calif. -November 10, 2009 - Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in...
Ingenix to Acquire CareMedic
Eden Prairie, Minn. and St. Petersburg, Fla., November 10, 2009 - Ingenix, a leading health information, technology and consulting company, today announced it will acquire CareMedic Systems, Inc., an industry leader in...
AdvanSource Announces Multi-Year Supply Agreement with International Manufacturer of Orthopedic Devices
WILMINGTON, Mass.--Nov. 10, 2009-- AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the Company has entered...
Life Technologies Signs Definitive Agreement to Acquire BioTrove
CARLSBAD, Calif.-- November 10, 2009-- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc....
University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom
CARLSBAD, Calif.-- November 10, 2009-- The University of Cambridge and Life Technologies Corporation (NASDAQ:LIFE), announced today the formation of a collaboration to advance translational research studies in key...
Life Technologies Signs Definitive Agreement to Acquire BioTrove
CARLSBAD, Calif. - November 10, 2009- Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc....
BioTrove Announces Formation of Subsidiary
Woburn, MA, November 10, 2009 - Biotrove announced today that it is forming a wholly owned subsidiary named BIOCIUS Life Sciences to hold the assets of the RapidFire Business Unit. Upon completion of Life Technologies...
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
Tuesday 10 November 2009, London, UK -- GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza...
Stryker Announces Agreements To Acquire Assets
KALAMAZOO, Mich., Nov. 10, 2009 -- Stryker Corporation (NYSE: SYK) announced today that it has acquired OtisMed Corporation, a privately held, software technology firm. OtisMed will focus on customizable instrumentation...
TEVA FILES AMENDED COMPLAINT AGAINST MOMENTA/SANDOZ TO INCLUDE INFRINGEMENT OF THREE COPAXONE
Jerusalem, Israel, November 10, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today it is seeking to amend its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent...
Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant
NATICK, Mass., Nov. 6, 2009 -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by...
Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm(TM) Electronic Data Capture Solution
WALTHAM, Mass.----Nov. 5, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which...
Toray Industries Agrees with TonenGeneral Sekiyu to Form a Joint Venture Through Investment in Battery Separator Film Business
November 4, 2009--TonenGeneral Sekiyu K. K. (Headquarters: Minato ku, Tokyo, President: Kazuo Suzuki) and Toray Industries, Inc. (Headquarters: Chuo ku, Tokyo, President: Sadayuki Sakakibara) have concluded a basic...
FDA GRANTS ORPHAN DRUG DESIGNATION FOR TNFERADE(TM)
GAITHERSBURG, MD - November 4, 2009 - GenVec, Inc. (NASDAQ: GNVC) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the treatment of pancreatic...
Flamel Technologies Announces Licensing Agreement with Pfizer
LYON, France--November 04, 2009 - Flamel Technologies (Nasdaq:FLML) today announced that Pfizer (NYSE: PFE) has exercised its option to license Flamel's Medusa
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference
SOUTH SAN FRANCISCO, Calif.-- November 4, 2009-- Exelixis, Inc. (Nasdaq: EXEL) announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009...
AGA Medical Receives Product Approvals in China
MINNEAPOLIS, Nov. 4, 2009 -- AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ: AGAM) has received regulatory approvals and licenses in China for its AMPLATZER
Aerocrine and Panasonic Shikoku Electronics enter into asthma partnership
SOLNA, Sweden - 4 November 2009 - Aerocrine AB (OMX Nordic Exchange: AERO) today announced that Aerocrine and Panasonic Shikoku Electronics, CO., LTD (PSEC) have entered into a long-term agreement to develop,...
Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs Against Chlorine Gas Exposure in Animal Studies
Mission Viejo, CA, November 4, 2009-- Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Health and McGill University have completed a series of preliminary studies...
AtriCure Announces Tentative Settlement with the Department of Justice
WEST CHESTER, Ohio--Nov. 4, 2009-- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to...
Phase Forward Teams with PharmaNet Development Group
WALTHAM, Mass.---Nov. 4, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group,...
Nabi Biopharmaceuticals Completes Sale of PentaStaph(TM) to GlaxoSmithKline PLC
ROCKVILLE, Md., November 4, 2009 -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has completed the sale of PentaStaph(TM) (Pentavalent S. aureus Vaccine) and related assets to GlaxoSmithKline PLC (GSK). The...
Monsanto Opens First Biotechnology Research Center in China
ST. LOUIS and BEIJING, November 4, 2009 -- Monsanto Company (NYSE: MON) announced today that it is opening its first research center in China, further demonstrating its commitment to forming technology collaborations in...
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease
04 Nov 2009 - Cambridge, MA - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review...
NEW MERCK BEGINS OPERATIONS WORLDWIDE
WHITEHOUSE STATION, N.J. - November 4 2009 - Merck & Co., Inc. (NYSE: MRK) today outlined its global strategy following the completion yesterday of Merck's merger with Schering-Plough Corporation. The new Merck,...
Shire Extends Agreement with Medidata Solutions for Trial Planning Products
NEW YORK, N.Y. - November 4, 2009 - Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced a multi-year contract extension with Shire plc (LSE: SHP,...
Foamix Extends Collaboration with Galderma
Rehovot (Israel), November 3, 2009 -- Foamix Ltd, a global leader in the development of dermatological foam medications today announced that the company has extended its agreement with Galderma to develop an innovative...
MERCK AND SCHERING-PLOUGH TO COMPLETE MERGER TODAY
WHITEHOUSE STATION and KENILWORTH, N.J.: November 3, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today....
Merck and Schering-Plough to Complete Merger Today
WHITEHOUSE STATION and KENILWORTH, N.J., November 3, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today....
Lonza integrates Innovative Technology in its Protein Design Services offering
Basel, 3 November 2009 - Lonza strengthens its protein design technology offering for biopharmaceutical development by acquiring Algonomics NV (Gent, Belgium). Algonomics is a contract research organisation providing...
President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department
DAR ES SALAAM, Tanzania, Nov. 3, 2009 - For the first time, emergency room services meeting international standards will be a part Tanzania's public health system, thanks to the opening of a new Emergency Medical...
Vironova receives nanomedicine grant
November 02, 2009 - Vironova is pleased to inform that the ERA-Net project titled I-CARE (Integrative nano-Composites And Regeneration of the Eye) has been recommended for funding. The research and development project...
Federal Court of Appeals Upholds Antitrust Liability Verdict Against Tyco HealthCare
Irvine, California - November 2, 2009 - Masimo (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals...
Bayer CropScience completes acquisition of biotech company Athenix Corp.
Monheim, November 2, 2009 - Bayer CropScience announced today the completion of its purchase of Athenix Corp., a privately-held independent biotechnology company headquartered in Research Triangle Park, North Carolina,...
Bayer CropScience completes acquisition of biotech company Athenix Corp.
Monheim, November 2, 2009 - Bayer CropScience announced today the completion of its purchase of Athenix Corp., a privately-held independent biotechnology company headquartered in Research Triangle Park, North Carolina,...
Taisho Completes Purchase of Certain OTC Drug Trademarks and PT Bristol-Myers Squibb Indonesia Tbk Shares Held by Bristol-Myers Squibb Company in Asia
November 2, 2009 --We are pleased to announce that Taisho Pharmaceutical Co., Ltd. (Head Office: Tokyo, Japan; "Taisho") has completed the acquisition on October 30, 2009 (Jakarta time; late-night October 31, 2009 Japan...
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
San Diego, CA - November 1, 2009 and Osaka, Japan - November 2, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a...
Bicycle Therapeutics and Pepscan enter into partnership to apply constrained peptide technology in the development of novel biotherapeutics
November 01, 2009--Bicycle Therapeutics has obtained a global license from Pepscan to utilize its proprietary constrained peptide chemistry technology. The parties propose to closely collaborate on the development of...
MERGE HEALTHCARE AND MEDRAD EXPAND EUROPEAN UNION DISTRIBUTION AGREEMENT
Milwaukee, WI, October 30, 2009 - Merge Healthcare (NASDAQ: MRGE), a health IT solutions leader, and MEDRAD, a leading provider of medical devices and services for diagnostic imaging, today announced an expansion of...
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx Installations
PORTO, Portugal, Oct. 30, 2009-- Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the...
Valeant to Acquire Polish Products
ALISO VIEJO, Calif., Oct. 30, 2009-- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has agreed to acquire the rights to several prescription and cosmetic dermatology products from a...
Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis
Vienna, Austria, October 30, 2009 - Intercell AG (VSE: ICLL) today announced that the Health Canada granted product approval for IXIARO
DSM to further explore growth opportunities in China
Heerlen,NL,30-Oct-2009 08:15 CET --Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that the contracts to establish nutrition and anti-infectives...
Uppsala University renews Simcyp academic licenses
30 Oct 2009--Simcyp is pleased to announce that Uppsala University, Sweden, has renewed its academic license agreement.
Sanofi-aventis to Acquire Oenobiol, French Leader in Nutritional Beauty Supplements
Paris, France - October 30, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into an agreement to acquire the company Laboratoire Oenobiol ("Oenobiol"), the French leader in...
Avesthagen brings French seeds giant Limagrain on board Atash Seeds in an IP based deal. The announcement was made in presence of Her Excellency Mrs. AnneMarie Idrac, Minister for Foreign Trade, Republic of France
Hyderabad, October 29, 2009:--AVESTHAGEN LIMITED today in the presence of Her Excellency Mrs. Anne Marie Idrac, Minister for Foreign Trade, Republic of France announced the formation of a joint venture company (JV)...
Norgine acquires cetilistat
October 26, 2009 -- Norgine BV today announced that it has purchased cetilistat, a novel treatment for obesity from Alizyme Therapeutics Limited. Norgine has acquired global rights to the product, including an...
Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
October 26, 2009 - Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has...
Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement
CLEVELAND and RESEARCH TRIANGLE PARK, N.C. - October 24, 2009 - Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive...
Merck and Schering-Plough Receive Approval From European Commission for Merger
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.---Oct. 23, 2009-- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they have received clearance from the European Commission (EC)...
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon (October 2009)
LOUISVILLE, Ky., Oct. 23, 2009 -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered...
Paladin Labs Inc. Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research From Gates Foundation
MONTREAL, CANADA--(Oct. 23, 2009) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company announced today that its Paladin Biosciences division has received a US$100,000 Grand Challenges...
Exclusive Distribution Agreement with Rosetta Genomics Inc.
October 23, 2009 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to advise that it has executed an Exclusive Test and Services Agreement with Rosetta Genomics Inc. ("Rosetta"), under which the...
Merck and Schering-Plough Receive Approval From European Commission for Merger
WHITEHOUSE STATION and KENILWORTH, N.J., October 23, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they have received clearance from the European Commission (EC)...
BD Announces Agreement to Acquire HandyLab, Inc.
Franklin Lakes, NJ (October 23, 2009) -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops...
Strategic Collaboration with Kineta
MATTAWAN, MI October 23, 2009: MPI Research announced that it will be collaborating with Kineta, Inc, a Seattle-based biotechnology company, in advancing their promising autoimmune drug development program. This...
Rosetta Genomics Names Genetic Technologies Limited Exclusive Distributor for Rosetta's microRNA-based Assays in Australia, New Zealand and Singapore
REHOVOT, Israel & PHILADELPHIA & MELBOURNE, Australia---Oct. 22, 2009-- Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG)...
Dual-labeled probe manufacturing license agreement
October 22, 2009 -- Eurogentec S.A. ("Eurogentec") announced today that it has obtained a license from Applied Biosystems', part of Life Technologies Corporation, ("AB") under AB's Probe Manufacturing License Program....
Covalon and Amsino International advance joint activities
MISSISSAUGA, Ontario - October 22, 2009 - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSX-V: COV), an advanced medical products company, announced that they have entered into a manufacturing agreement with...
Evotec Receives a EUR 2.5 Million Milestone Payment in its Research Collaboration with Boehringer Ingelheim
Hamburg, Germany - October 22, 2009: Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) today announced that it has achieved another milestone in its research collaboration with Boehringer Ingelheim. The...
SKion GmbH makes a new, improved Tender Offer for Acquisition of ALTANA Shares
Wesel, October 22, 2009--Today SKion GmbH informed us about their decision to make a new, improved offer for the acquisition of shares in ALTANA AG and they have published this decision today according to
Corvitex and to-BBB join forces to raise funds in the USA
Raleigh (NC, USA), Leiden (Netherlands), October 21st 2009 - Corvitex, the US based global market services firm, and to-BBB, the Dutch brain drugdelivery company, have signed a "Marketing & Sales Support Agreement." The...
Institute for Systems Biology, Agilent Technologies to Build MRM Atlas for Quantification of All Human Proteins
SEATTLE, Wash., and SANTA CLARA, Calif., Oct. 21, 2009--The Institute for Systems Biology (ISB) and Agilent Technologies Inc. (NYSE: A) today announced a collaboration to create the Human Multiple Reaction Monitoring...
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
Ottawa, Ontario/October 21, 2009 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today advises that the Securities Lending Agreements ("SLA") between SC Stormont Holdings Inc. ("Stormont")...
Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping
HONOLULU--Oct. 21, 2009-- At the 59th annual meeting of the American Society of Human Genetics, Illumina, Inc. (NASDAQ:ILMN) today announced its 2010 roadmap for the Infinium whole-genome genotyping platform, offering...
Gamida Cell and Cellerix Partner on Feasibility Study
Jerusalem, Israel and Madrid, Spain, October 21, 2009 --- Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the...
Avacta Group plc Placing
October 21, 2009--Avacta Group plc ("Avacta" or "the Company"), the biophysics company which provides innovative high value technologies and services to the pharmaceutical and diagnostics markets, announces that it...
Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Paris, France - October 21, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Wellstat Therapeutics Corporation announced today a global licensing agreement on PN2034, a novel oral first-in-class, insulin...
Novavax and Xcellerex Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine
Rockville, MD and Marlborough, MA - October 21, 2009 - Novavax, Inc. (NASDAQ: NVAX) and Xcellerex, Inc. has entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process...
SemBioSys provides an update on Botaneco
CALGARY, Oct. 21, 2009 - SemBioSys Genetics Inc. ("SemBioSys") (TSX:SBS) today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of...
ScImage Receives Canadian Medical Device Licence for PicomEnterprise
Los Altos, CA - October 21, 2009 - ScImage, a leading enterprise imaging and informatics company, announced today that it has received a Class II Medical Devices Licence from Health Canada. The issued licence clears...
Apotex to Distribute Important Transdermal System for Management of Chronic Pain in the U.S. Market
Weston, FL -October 20, 2009 Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical Company of Japan. Apotex will sell to the U.S. healthcare market, Hisamitsu's...
Lpath Receives Grants From the National Institutes of Health and Publishes Key Paper in the Proceedings of the National Academy of Sciences
SAN DIEGO, CA, October 20, 2009 -- The National Cancer Institute's Small Business Innovation Research (SBIR) Program has awarded Lpath (OTCBB: LPTN), the category leader in lipidomics-based therapeutics, two Phase 1...
Agfa HealthCare's DX-S System Recognized for Advances in Neonatal Imaging by Premier Healthcare Alliance
Mortsel, Belgium/ Greenville, SC (U.S.) October 20, 2009 CR is a technology that allows X-rays to be digitally captured, reviewed and archived. The DX-S CR system uses groundbreaking technologies, proprietary to Agfa...
Evotec Signs Agreement with DiscoveRx Corporation to Support High Throughput Screening Services
Hamburg, Germany / Oxford, UK - October 20, 2009 - Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC), a leading provider in the discovery and development of novel small molecule drugs and DiscoveRx Corporation...
Icagen Describes Progress in Its Collaboration With Pfizer to Identify Selective Sodium Channel Inhibitors
RESEARCH TRIANGLE PARK, N.C., October 19, 2009 -- Icagen, Inc. (Nasdaq:ICGN) today announced that data related to its collaboration with Pfizer focused on certain sodium channels for the treatment of pain and related...
New Pfizer Animal Health is Unveiled with Acquisition of Wyeth
NEW YORK--October 19, 2009--A new Pfizer Animal Health was unveiled last week as Pfizer's acquisition of Wyeth, including its subsidiary Fort Dodge Animal Health, was completed. Pfizer Animal Health is now the world's...
Maxxam Analytics acquires CANTEST, BC's leading independent laboratory
MISSISSAUGA, ON, and BURNABY, BC, October 19, 2009 - Maxxam Analytics International Corporation - an OMERS Private Equity portfolio company - announced today that it has acquired Burnaby, BC-based CANTEST Ltd.,...
Agfa HealthCare installs first DX-D 500 digital X-ray room in France, signs agreement for second installation
Mortsel, Belgium October 16, 2009 Uniting the digital technology of the DX-D 500 with MUSICA2 image processing optimized for DR, users of the solution can obtain immediate previews on the company's advanced NX...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
